Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 9Stomach Neoplasms 6Lung Neoplasms 4Uterine Cervical Dysplasia 2Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Esophageal Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Uterine Cervical Neoplasms 1Stage IV Gastric Cancer With Metastasis 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasms 1Pancreatic Neoplasms 1Neurotoxicity Syndromes 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Eunuchism 1Erectile Dysfunction 1Delirium 1Chemotherapy-induced Peripheral Neuropathy 1Carcinoma, Ovarian Epithelial 1Breast Cancer Organoids 1Brain Neoplasms 1Agnosia 1

Interventions

Surveys and Questionnaires 1Pemetrexed 1Paclitaxel 1Neoadjuvant Therapy 1Mental Status and Dementia Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Delirium × Paclitaxel × Clear all
NCT05273827 2024-01-05

Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium

Tianjin Medical University Cancer Institute and Hospital

Completed
81 enrolled

Agnosia, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡